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ABSTRAK 
Objektif: Kajian prospektif ini melaporkan prevalen kecacatan pendengaran 
di kalangan pesakit yang menerima rawatan di dalam Unit Neonatal (bayi yang 
telah menerima rawatan di unit rawatan rapi dan yang menghadapi masalah 
kurang serius). Rekabentuk kajian: Dari 15hb. Februari hingga 15hb. Mac, 2000 
dan dari 15hb. Februari hingga 15hb. Mei, 2001, seramai 401 orang bayi telah 
menjalani ujian saringan pendengaran dengan menggunakan "transient evoked 
otoacustic emissions" diikuti ujian saringan kedua untuk bayi-bayi yang gagal di 
dalam ujian pertama. Keputusan: 370 (92.27%) orang bayi telah lulus saringan 
pertama untuk kedua-dua belah telinga. Lapan (2%) orang bayi telah gagal 
untuk sebeJah telinga manakala 23 (5.74%) orang bayi telah gagal untuk kedua-
dua belah telinga, menjadikan sejumlah 7.740/0 daripada bayi-bayi tersebut 
dicadangkan untuk menjalani ujian saringan kedua. Seramai lima daripada dua 
puluh satu orang bayi yang telah hadir untuk saringan kedua telah gagal di 
dalam ujian tersebut menjadikan prevalen kecacatan pendengaran sebanyak 
1.28°A>. Kecacatan kepala dan muka, berat lahir yang sangat rendah, 
penggunaan ubat "ototoxic", stigmalsindrom yang berkaitan dengan kecacatan 
pendengaran dan "hyperbilirubinaemia" pada tahap yang memerlukan 
pertukaran darah telah dikenalpasti sebagai factor-faktor risiko untuk kecacatan 
pendengaran. Purata masa yang diambil untuk satu-satu ujian ialah 5.43 minit. 
"Apgar score" yang rendah dan ventilasi mekanikal melebihi 5 han telah 
didapati tidak berkaitan dengan kecacatan pendengaran di dalam kajian ini. 
IX 
ABSTRACT 
Objective: this prospective study reports on the prevalence of hearing 
impairment in neonatal unit population (NICU graduates and less severe ill 
infants). Design: from 15th February, 2000 to 15th March, 2000 and 15th 
February, 2001 to 15th May, 2001, 401 neonates were screened with transient 
evoked otoacoustic emissions (TEOAE) followed by second stage screening of 
the infants who had failed the initial test. Results: 370 (92.27°.4,) infants passed 
the primary screen for both ears. Eight (2%) infants failed one ear and twenty 
three (5.74%) infants failed both ear, adding up to 7.740/0 planned for second 
stage screening. Five out of twenty two infants who had come for the follow up 
failed the screening resulting the prevalence of hearing impairment of 1.28%. 
Craniofacial malformations, very low birth weight, ototoxic medication, stigmata I 
syndromes associated with hearing loss and hyperbilirubinaemia at the level of 
exchange tranfusion were identified to be independent significant risk factors for 
hearing impairment. The mean total test time was 5.43 minutes. Poor apgar 
score and mechanical ventilation of more than 5 days were not found to be 
associated with hearing impairment in the present study population. Conclusion: 
Hearing screening in high-risk neonates revealed a total of 1.28%, with hearing 
loss. Significant risk factors were craniofacial malformations, very low birth 
weight, ototoxic medication, stigmata I syndromes associated with hearing loss 
xi 
and hyperbilirubinaemia at the level of exchange tranfusion. Other perinatal 
complications did not significantly influence screening results indicating 
improved perinatal handling in a neonatal population at risk for hearing 
disorders. 
XlI 
CHAPTER 1 
INTRODUcrlON 
CHAPTER 1 
INTRODUCTION 
The proverb says, " As we hear, so shall we speak. n It is this intimate 
relationship between speech, language and hearing that has fascinated man 
since the beginning of time. Many believe that language is inherent in each 
child's maturation, needing only the appropriate environment to trigger the 
process. Speech and language are naturally and easily acquired by most 
children. However, the child with hearing loss does not automatically develop 
speech and may be confronted with a life of language difficulties and 
educational struggles. Because hearing loss in infants typically is a silent and 
hidden handicap, identification and treatment of the problem is often delayed. 
Undetected hearing loss can lead to delayed or impaired speech and language 
development, social and emotional problems, underachievement and academic 
failure. 
1.1 Epidemiology 
Significant hearing loss is one of the most common major abnormalities 
present at birth. It is the most common birth defect in America today (Sorensen, 
1998). Hearing impairment ranging from mild to profound. Even mild hearing 
impairment seriously affects language, speech and cognitive development 
(yoshinaga-Itano, 1998). Early identification and intervention lead to improved 
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communication skills, which positively impact psychosocial, educational and 
vocational development. 
Permanent hearing impairment occurs with a prevalence of about one to 
three per 1000 live births (Watkin, 1995, Finitzo et aI., 1998, Mason and 
Hermann, 1998, Vohr et aI., 1998, Watkin and Baldwin, 1999). The occurrence 
of hearing loss is considerable greater in certain sub-populations, ranging from 
1 to 5 in 100 in neonatal intensive care populations and groups of infants 
selected by current at-risk registers (Shannon et aI., 1984, Watkin et aI., 1991, 
Watson et aI., 1996, Hess et aI., 1998, Mason et aI., 1998, Meyer Jan et aI., 
1999). Studies indicate that screening by high risk registry alone leads to the 
identification of at best only 50-75 percent of infants with hearing loss (Watkin et 
al., 1991, Hess et aI., 1998, Sorensen, 1998, Task Force on Newbom and 
Infant Hearing, 1999). 
About half of all moderate to profound permanent bilateral hearing loss 
present at birth or occurring in early childhood is associated with genetic 
factors; one third occurring in syndromic form. Dominant inheritance accounts 
for about 10%; recessive inheritance for up to 400/0; and sex-linked patterns 1-
2%. Another 10-200/0 occurs as a result of congenital infection, with some 10-
150/0 a by-product of prematurity or a perinatal complication, such as asphyxia, 
elevated bilirubin or respiratory distress. The remaining 30°A, of all hearing loss 
present in early childhood has no obvious cause. 
As far as the author may concern, there is no published study either 
internationally or locally regarding the prevalence of hearing loss in Malaysia. 
However, there was a study done by Ass. Prof. Dr Din Suhaimi to determine the 
high risk factors for deafness of children in Kelantan. He found that 14.70/0 of the 
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patients had family history of hearing loss, 6.7% had been ventilated for more 
than 10 days, 4.0% had received ototoxic medications for more than 5 days, 
2.7% each for the patients who has malformation in the head and neck region, 
birth weight less than 1.5 kg, hyperbilirubinaemia and with history of bacterial 
meningitis, 1.30/0 has congenital infection and the remaining 62.5% has no 
obvious cause. 
1.2 Development Of The Human Central Auditory System 
The inner ear is nearly fully developed at birth, and the brain stem develops 
during the perinatal period and becomes fully mature within the first 2 or 3 years 
of life (Roizen & Dieffendorf, 1999, Garganta & Seashore, 2000). Cortical 
development is somewhat delayed, but with the exception of its commissural 
connections, the human auditory cortex also reaches a stage of relative maturity 
by age 2 or 3 years. 
Although the primordial of auditory centres are identifiable by the third to 
eight prenatal weeks, the first signs of expansion of the brain stem auditol)' 
pathway occur at the 16th to 20th weeks of gestation, when neurons develop 
visible cytoplasm, and neurofilament-containing axons proliferate in the auditory 
nerve, trapezoid body and lateral lemniscus. During the 24th to 26th gestational 
weeks, these axons undergo terminal branching within their target nuclei, and 
the first short dendrites appear on neurons in the cochlear, olivary, and 
collicular nuclei. The coincidental development of axon terminals and dendritic 
processes probably reflects the first appearance of synapses, preparatory for 
the onset of function, at around the 28th gestational week. The onset of 
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synchronized conduction at this time is signalled by the simultaneous 
appearance of acousticomotor reflexes, recordable ABRs and myelin in the 
auditory nerve and brain stem pathways. During the 3 months between onset of 
transmission and term birth, increased myelin density is reflected in rapidly 
increaSing conduction velocity in auditory pathways. The result of this rapid 
maturation is that axonal conduction time through the brain stem reaches the 
adult value by the time of term birth; synaptic transmission time lags somewhat 
behind axonal transmission, but the latency of impulses crossing synaptic pOints 
in the cochlear nuclei and olivary nuclei is adult-like by age 1 or 2 years. 
Auditory cortex maturation occurs later than that of the brain stem in that, at 
term, it is only half of its adult thickness, and its laminar pattern of 
cytoarchitecture is indistinct. At approximately the fourth postnatal month, 
neurofifament-containing axons begin to sweep into the cortex in parallel arrays 
and penetrate layers 4, 5, and 6. Myelination of afferent and efferent axons in 
these deeper layers occurs at approximately 11 months of age, coincident with 
the onset of speech production, but axonal density continues to increase until 2 
or 3 years of age. Layers 2 and 3, which are the source and terminus of 
commissural axons passing through the corpus callosum, remain only sparsely 
filled with mature axons until several years later, when interhemispheric sensory 
transfer begins to mature. 
In summary, development in the brain stem auditory pathway parallels that 
of the inner ear in that both begin to function several months before birth. This 
preparation for immediate function allows newborns to process sounds and 
accurately analyse their loudness and pitch. It also underlies infant's ability to 
carry out tasks that involve central neural processing, such as integration of 
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input to the two ears to localize a sound source or discrimination of specific 
speech sounds. The shift in perceptual ability that occurs in infants in the 
second half of the first year of life, with a preference for the sounds and patterns 
of their native language, probably reflects the beginning of cortical maturation 
and its influence on the perceptual process. 
1.3 Speech Perception 
The ability of human neonates to hear, remember, and discriminate speech 
sounds has been demonstrated in stUdies using differential cardiac response, 
sucking rate, or conditioned head turning to familiar versus novel sounds. Soon 
after birth, human infants show a greater response to vowels than to tones or 
noise and remember previously heard speech sounds for at least 24 hours. At 2 
or 3 months of age, speech sounds such as consonant pairs, are discriminated 
across the same boundaries as are used by adults. In the first month life, infants 
detect changes in word order in sentences and retain more information about 
two-syllable phrases that share an initial consonant and vowel. 
Changes that suggest that infants are beginning to learn about the 
organization of sound patterns in their native language occur in the second half 
of the first year of life. One to four-month-old infants make speech syllable 
contrasts equally well in their parental language. By 6 months of age, infant can 
accurately categorize variants of vowels that appear in the language to which 
they have been exposed. This demonstrates the effects of very early 
experience on developing speech perception ability and provides evidence that 
very young infants process speech and form important neural connections long 
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before it is apparent. Speech perception development continues into childhood, 
but the ability to alter speech sound categories with experience falls off 
dramatically with age. 
1.4 Aetiology Of Hearing Loss In Children 
The frequency of the various causes of hearing loss in children has changed 
over the past 30 years and will probably continue to change as newborn hearing 
screening becomes available to all children and as we develop more ways to 
prevent hearing loss. The greatest victories in the arena of prevention of 
hearing loss in children have been in the infectious diseases. Congenital rubella 
has become almost nonexistent in the United States with the introduction of the 
vaccine. With the introduction of the Haemophilus influenza 8 vaccine, the 
bacterial meningitis that has been responsible for most meningitis-induced 
hearing loss has been enormously decreased. These advances have resulted in 
hereditary causes and neonatal intensive care unit (NICU) graduates 
contributing most children with hearing loss. 
As mentioned before, most report assign approximately 50% of childhood 
hearing impairment to genetiC factors; 20% to 300/0 to prenatal, perinatal, or 
postnatal environmental causes; and 25% to 30% to uncertain causes. 
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1.4.1 Hereditary Hearing Impainnent (HHI) 
Approximately 80% of HHI is inherited as an autosomal recessive trait, 18% 
autosomal dominant, and approximately 2% X-linked recessive (Tomaski & 
Grundfast, 1999). Rarely, HHI can be inherited as a result of a defect in the 
mitochondrial rather than nuclear DNA. The total number of genes that can 
cause all types of HHI has been estimated to be approximately 200 (Tomaski & 
Grundfast, 1999), and significant progress is being made in locating the 
involved genes. 
Genetic hearing loss may exist with associated anomalies (syndromic 
hearing loss) or be present alone (isolated hearing loss without associated 
findings). Two thirds of cases of HHI are nonsyndromic, whereas one third of 
cases of HHI have associated clinical symptoms. Thus, more children have 
hereditary deafness that has no associated findings with the deafness. During 
the past few years, mutations of multiple genes have been identified that result 
in nonsyndromic hearing loss. They include 16 autosomal dominant forms 
(deSignated DFNA1-DFNA17), 25 autosomal recessive forms (DFNB1-
DFNB25)(Green et aI., 1999), and 4 X-linked forms (DFN1-DFN6)(Garganta & 
Seashore, 2000). Knowledge of these genes and the mutations that result in 
hearing loss often allows genetic testing of a hearing impaired child. 
1.4.1(a) Autosomal Recessive Syndromes 
Recessively inherited hearing impairment accounts for approximately aOok of 
HHI (Tomaski and Grundfast, 1999), which means that most children with HHI 
may not have affected relatives in previous generations. For this type of 
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inheritance to occur, the affected individual must have inherited two abnormal 
genes, one from each parent. Thus, these children often are the offspring of 
parents without any sign of hearing impairment who carriers of a single 
recessive gene for hearing impairment. Mutations in the gene for connexin-26 
(gap junction protein 82, [GJB21 gene) are thought to be responsible for half of 
the severe-te-profound autosomal recessive nonsyndromic hearing loss. Green 
et al. (1999) found that 3% of the general population in the Midwestern United 
States earned mutations in this gene and that 2.50/0 of the population carried the 
most common mutation, 35de1G. They also found that 42% of hearing-impaired 
children without a family history of hearing loss had mutations in connexin-26. In 
another study, Estivill et al. (1998) found that 37% had mutations in the gene. 
The syndromic group include Usher Syndrome, Pend red Symdrome, Jervell 
and Lange-Nielsen Syndrome and 8ranchie-Otorenal Syndrome. 
1.4.1(b) Autosomal Dominant Syndromes 
The syndromic group include Alport Syndrome, Mandibulofacial Dysostosis 
(Treacher-Collins) Syndrome, Neurofibromatosis, Stickler Syndrome (Marshall-
Stickler Syndrome, Hereditary Arthro-Ophthalmolopathy) and Waardenburg 
Syndrome Syndrome. Nonsyndromic autosomal dominant delayed-onset 
progressive sensorineural deafness is a relatively common type of hearing 
impairment. The hearing loss usually begins in the second or third decade and 
can progress to profound deafness involving both ears. Two genes causing 
dominant progressive hearing impairment have been located, one on 
chromosome 1 p and one on chromosome 5q (Mhatre & Lalwani, 1996). Another 
form is dominant early-onset progressive sensorineural hearing loss. Usually, 
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affected individuals develop high-frequency sensorineural hearing loss during 
the first decade of life, and hearing impairment progresses to more frequencies 
with increasing age. 
1.4.1(c) X-Linked Recessive Syndromes 
X-linked refers to genes found on the X chromosome. Most X-linked hearing 
loss genes are recessive. Females with an X-linked hearing loss gene most 
likely have a dominant gene for hearing on their second X chromosome and are 
therefore carriers. A carrier has a 50% chance of passing on the hearing loss 
gene. If a boy receives the hearing loss gene, he will manifest the hearing loss. 
X-linked congenital sensorineural hearing loss and X-linked hearing loss with 
stapes fixation and perilymphatic gusher are included in this group. 
1.4.1 (d) Mitochondrial Syndromes 
Mitochondrial inheritance contributes less than 1 % of all HHI. Transmission 
occurs from affected females. Abnormalities of mitochondrial DNA can produce 
either an isolated hearing loss or a hearing loss associated with other features 
of mitochondrial disorders. These include lactic acidosis, encephalopathy, 
myopathy, seizure disorder, ophthalmoplegia, diabetes mellitus, 
cardiomyopathy, strokelike episodes, ataxia, and optic atrophy. 
1.4.2 Hypoxia 
Most studies of the cause of hearing loss in N leu graduates have identified 
hypoxia to be a factor. In different studies, hypoxia has been defined differently. 
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Hypoxia may be defined as apnoea, a difficult delivery, a history of duration of 
ventilation, a lower Apgar score at 5 minutes, or documented P02 of less than 
50 mm Hg (Roizen, 1999). Bergman et al. (1985) identified 36 children with a 
sensorineural hearing loss of less than 55dB bilaterally in their NICU follow-up 
program, which included all infants of less than 1500 g birth weight or with 
neonatal seizures. One of the significant neonatal predictors of hearing loss in 
high-risk premature infants was prolonged respirator care (p = 0.0004). Salamy 
et al. (1989) studied prospectively 12 infants with sensorineural hearing loss 
from a group of 224 very low birth weight «= 1500 g) infants requiring NICU 
care. They found that the infants with hearing loss had a P02 less than 50 mm 
Hg more frequently than the control infants (p < 0.01). However, the precise 
pathophysiologic mechanism responsible for the SNHL is not clear in all cases 
(Brookhouser, 1996). 
1.4.3 Persistent Pulmonary Hypertension and Extracorporeal Membrane 
Oxygenation 
Persistent pulmonary hypertension or persistent fetal circulation occurs as a 
result of failure of the circulatory adaptation at birth with the high pulmonary 
vascular resistance in utero continuing and causing right-te-Ieft shunting at the 
levels of both of the foramen ovale and ductus arteriosus. Persistent pulmonary 
hypertension, primarily a disorder of full-term infants, is manifested by continued 
severe hypoxaemia despite conventional ventilatory management. Management 
of infants with the disorder includes hyperventilation and/or the use of 
pulmonary vasodilators such as tolazaline. Hendricks-Munoz et at (1988) found 
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that the incidence of hearing loss for infants with persistent pulmonary 
hypertension is 52.5% if the infants with assumed normal hearing are excluded. 
Nevertheless, they speculated that the increased observation of hearing loss 
with the disorder might be due to aggressive hyperventilation associated with 
diuretic therapy. (15) However, Marron et al. (1992)(16) in their follow-up study 
of 27 children with PPHN found none to have SNHL. 
ExtracorporeaI membrane oxygenation (ECMO) is a complex technique for 
providing life support in respiratory failure. This technique oxygenates blood 
outside the body, obviating the need for gas exchange in the lungs, and if 
necessary, provides cardiovascular support (UK Collaborative ECMO Trial 
Group, 1996). Kawashiro et al. (1996) found that 8 of 10 children who 
developed hearing loss after discharge from the NICU had PPHN, and 6 of the 
8 had required ECMO. Desai et al. (1997) found SNHL in 12 (15%) of 80 
ECMO-treated children. 
1.4.4 Hyperbilirubinemia 
Elevated serum bilirubin during the neonatal period, sufficient to permit 
passage through the blood-brain barrier, can result in deposits in the basal 
ganglia, including the ventrocochlear nucleus, leading to neurologic sequelae 
(Brookhouser, 1996). In the presence of hyperbilirubinaemia, specific 
aberrations appear in brain stem responses (ABRs). These aberrations 
disappear after exchange transfusion and the establishment of a normal 
bilirubin level (Perlman et al., 1983). De Vries et al. (1985) studied the 
relationship of serum bilirubin level to ototoxicuty and deafness. They found that 
11 
the mean duration of hyperbilirubinaemia was significantly longer in the deaf 
infants (p<0.02). They also concluded that in healthy preterm infants with birth 
weight greater than 1,500 g, high bilirubin levels carry little risk, whereas a 
serum bilirubin level greater than 240 JlmollL in high risk preterm infant with 
birth weight of 1 ,500 g or less is associated with a high risk of deafness. In a 
study of 56 children of less than 1000 g birth weight, Doyle et al. (1992) found 
that all of the four children with SNHL had significantly higher maximum 
concentrations of bilirubin in the newborn period (median 167 Jlmoi/L vs 138 
JlmoIlL). Bergman et al. (1985), in their study of a group of NICU graduates with 
a birth weight of up to 1500 g or neonatal seizures found that maximum serum 
bilirubin levels were one of several independent predictors of hearing loss (p = 
o. 0057) and that a negative correlation was found with the number of exchange 
transfusions (p = 0.0207). 
1.4.5 OtotOXic medications 
Aminoglycoside antibiotics are known to cause sensorineural hearing loss in 
adults, especially in the presence of renal impairment, concomitant use of 
diuretics, or prior use of other aminoglycosides. To what extent these drugs are 
aSSOCiated with ototoxicity in newborn infants is unclear. A divergent view is that 
the newborn infant, especially the pretenn infant, is at greatest risk for 
ototoxicity because of renal immaturity and the presence of multiple organ 
system disease that may act singly or synergistically with aminoglycosides to 
damage the inner ear. 
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Using ABR, Bernard (1985) reported a larger incidence of hearing loss in 26 
premature infants given gentamicin or tobramycin than in an age-matched 
nontreated control group. However, several other studies of the factors 
associated with SNHL in NICU graduates have not found the use of 
aminoglycosides in the NICU to be a significant predictor of SNHL (Bergman, 
1985, Finitzo-Hieber, 1985, Salamy, 1989, Hess et aI., 1998, Meyer Jan et aI., 
1999). 
Studies of frusemide in the neonatal period, especially with greater amounts 
of administration for longer durations and in combination with aminoglycosides, 
are associated with an increased risk for hearing loss (Salamy, 1989). 
1.4.6 Meningitis 
Bacterial meningitis has been the leading cause of acquired SNHL in 
children. Serial recordings of BAEP beginning within 48 hours of admission 
have shown the early occurrence of hearing loss, with a possible recovery or 
worsening occurring during the first 2 weeks with no cases of "late" deafness or 
"late" recovery (Kaplan et aI., 1984, Vienny et aI., 1984). Clinical and 
experimental research indicates that the hearing loss after meningitis is caused 
by cochlear damage by ototoxic drugs used to treat the meningitiS or to direct 
damage to the cochlea by the meningitis (Francois et aI., 1997). In a study of 
432 children with meningitis, Woolley (1999) found that 59(13.70/0) had the 
development of hearing loss. Of these 59 children, 46(78.00/0) had stable 
sensorineural hearing loss and 13 (22.00/0) had either progressive or fluctuating 
hearing loss. Streptococcus pneumonia appears to be the most virulent in 
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causing hearing loss, with 23.8% of the children having pneumococcal 
meningitis in this study so affected. In another study, Dodge (1984) found that 
overall 10.3% of the patients had persistent bilateral or unilateral SNHL, with 
Streptococcus pneumoniae having the highest incidence (310/0), followed by 
Neisseria meningitidis (10.5%) and H. influenzae (6%). In one study of 80 
children with meningitis caused by N. meningitidis, 90/0 developed SNHL 
(Edwards et aI., 1981). S. pneumoniae not only has had the highest frequencies 
of SNHL but also has high mortality rates and neurologic morbidity (Wald et al., 
1986). Little is reported about hearing loss in children with fungal infections, but 
one study reported 3 children out of 7 children with fungal meningitis developed 
SNHL (Roizen, 1999). There have been no studies of the sequelae of viral 
meningitis that have reported SNHL (Wilfert et aI., 1981). 
1.4.7 Congenital Infections 
1.4.7(a) Cytomegalovirus 
Cytomegalovirus infection occurs in 0.2% to 2.2% of all newborns, making it 
the most common intrauterine infection in humans (Roizen, 1999). Ramsay 
(1991) found that up to 100/0 of children with congenital CMV infection exhibit 
systemic and neurologic symptoms at birth, and 61 % of these children develop 
SNHL. Fowler (1997) prospectively evaluated 307 children with documented 
asymptomatic congenital CMV infection and found that 22 (7.20/0) had SHNL. 
Among the children with hearing loss, further deterioration of hearing occurred 
in 50.0010, with the median age at first progression at 18 months. Delayed-onset 
SNHL was observed in 18.2% of the children, with the median age of detection 
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at 27 months. Fluctuating SNHL was documented in 22.70/0 of the children with 
hearing loss. Eleven of the children had unilateral losses, and 12 of the ears 
had a severe to profound hearing loss. The authors speculated that more 
children with asymptomatic CMV would probably develop late-onset hearing 
loss and recommend that children with congenital CMV have continued 
monitoring of their hearing status. 
1.4.7(b) Herpes Simplex Infection 
Neonatal herpes simplex virus (HSV) infection is a rare but potentially fatal 
disease that occurs in 1 in 2500 to 1 in 10,000 pregnancies. In one study, the 
neurologic impairment, including hearing loss, is found in most children with the 
disseminated presentation, 40% of the children with encephalitic presentation, 
and 25% of children with infection confined to the skin, mouth or eyes (Roizen, 
1999). 
1.4.7(c) Congenital Rubella 
Hearing loss is the most common permanent manifestation and affects 68°A, 
to 930/0 of children with congenital rubella (Roizen, 1999). Das (1996) found that 
18 out of 339 patients with SNHL have congenital rubella. However, since the 
introduction of the rubella vaccine, the number of congenital rubella cases 
continues to decrease. 
1.4.7(d) Congenital Syphilis 
Hearing loss is one of the late manifestations of syphilis and occurs after 2 
years of age. The hearing loss results from persistent, active disease with 
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ongoing inflammation and scarring. Prevalence estimates for SNHL range from 
3% to 38%, with more than one third of these patients becoming symptomatic 
prior to age 10 years (Brookhouser, 1996). 
1.4.7(e) Congenital Toxoplasmosis 
In one study, they found that 10% to 15% of children with congenital 
toxoplasmosis developed educationally significant hearing loss (Roizen, 1999). 
In a group of 30 children who had been treated at birth with pyrimethamine and 
sulfonamide, they reported no development of hearing loss. 
1.4.8 Noise-Induced Hearing Loss 
The evidence that fetuses and newborns exposed to excessive noise may 
suffer SNHL is unclear. In one study, children with high-frequency hearing loss 
tested at 4 to 10 years of age were more likely to have been born to women 
who were exposed consistently to occupational noise in the range of 85 to 95 
dB during pregnancy {Committee on Environmental Health, 1997}. Other 
studies have been inconsistent in relation to exposure to excessive noise 
(Roizen, 1999). 
Many studies have documented the continuous noise exposure associated 
with NICUs varies from 60 dB to 80 dB (Brookhouser, 1992), with intense short 
duration noise from such things as the cloSing of the metal cabinet doors (90 
dB) and dropping the head of the mattress (120 dB) {Committee on 
Environmental Health, 1997}. Many studies have documented hearing loss in 
children cared for in NICU (Bergman et ai, 1985). 
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1.4.9 Hypothyroidism 
Rovet (1997) retrospectively studied 101 children followed longitudinally to 
eveluate newborn screening for hypothyroidism. Of seventy-five children who 
had previously had their hearing tested, 15 (20%) had hearing loss: 5 were 
conductive, 2 unilateral, and 3 bilateral; 9 sensorineural (1 unilateral, 8 bilateral; 
1 child had bilateral sensorineural and conductive losses). The hearing loss was 
mild (21-40 dB) in 10 cases, moderate (41-55 dB) in 2 cases, and moderately 
severe (56-70 dB) in 3 cases. The children with hearing loss differed from the 
children without hearing loss in age treatment onset (22 vs 14 days) but not in 
disease severity or duration. 
1.5 Screening 
Screening is an all-encompassing term, which is defined as the preliminary 
acquisition of information for early detection of a condition. More speCifically, 
screening is a process of applying certain rapid and simple tests and 
procedures to a generally large population to identify individuals with a high 
probability of having the target condition from individuals who probably do not 
have the disorder. Two important considerations are implicit in the above 
definitions: (1) screening is an issue of likelihood probabilities rather than a 
certainty of accuracy - the identification of persons who are likely to have the 
disorder from those who probably do not have the disorder and (2) screening 
must not be misconstrued into the totally separate issue of diagnosis. In short, 
individuals identified with a "positive outcome" during the screening procedure 
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must be considered only "at risk" for the problem until careful diagnostic testing 
can determine accurately the presence or absence of the disorder. 
1.6 The need for an early hearing screening 
The first 3 years of life are the most important for speech and language 
acquisition. The issue of early versus late treatment for hearing impainnent 
seems clear: the future of a child born with significant hearing impairment who 
is not identified and provided with appropriate intervention, has no way to 
acquire the fundamental language, social and cognitive skills required for later 
schooling and success in society. Language is essential to learning: the earlier 
intervention begins for youngsters with hearing impairment, the more likely they 
are to develop communication skills on par with their normal hearing peers. 
Yoshinaga-Itano et. al (1998) compared the receptive and expressive 
language abilities of hard-of-hearing children whose hearing losses were 
identified by 6 months of age with the children whose hearing losses were 
identified after the age of 6 months. The language quotient (age equivalent of 
attained language skills divided by chronological age) of children with normal 
cognition (intelligent) was significantly better in the group that was identified 
early (mean = 91) than in the group that was identified later (mean = 70). This 
degree of difference was found at all ages at follow-up between 13 and 36 
months and with all methods of communication (oral vs sign or combination). 
The difference between language quotients of the two groups was greater with 
more severe hearing loss. Although the group that was identified later had a 
lower cognitive quotient (88 in the early vs 76 in the later group), the difference 
18 
in language quotient persisted when the children were stratified by cognitive 
quotient. This suggested that early identification and intervention was 
responsible for the higher language quotient in the group that was identified 
early. There was no difference in the language quotients in the subgroups of . 
children who were identified later (6 to 12 months, 12 to 18 months, 18 to 24 
months), which provides additional evidence that auditory stimulation in the first 
few months of life is critical for normal language development. Nikolopoulos et 
al. (1999) did a prospective study to assess the influence of age at implantation 
on speech perception and speech intelligibility following paediatric cochlear 
implantation. They found that the age at implantation is positively correlated 
with preimplantation assessment performance and with most of the outcome 
measures up to 24 months following implantation. 
Animal studies show that early auditory deprivation interferes with the 
development of neural structures necessary for hearing. Mice deafened at birth 
show a marked decrease in the size of the cochlear nucleus. This change does 
not occur if the animals are deafened after hearing develops (7 days) and is 
reversible in gerbils if hearing is restored during the first week of life (Garganta 
& Seashore, 2000). Human infants with hearing loss, particularly those with 
sensorineural impairments, may experience similar disruptions that will have a 
direct impact on language acquisition. Other factors can further exacerbate the 
consequences of hearing impairment. For example, some children have 
additional sensory disabilities and I or associated neurological disorders that 
further interfere with perceiving and processing infonnation. Environmental 
factors, such as the quality of language input provided by the parents, can 
either faCilitate or impede communication skills. Socioeconomic-related factors, 
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such as the lack of access to the health care, other associated health problems, 
high-risk populations and social stresses also may exacerbate the 
consequences of deficits. 
1.7 Limitations of current methods 
The need for the early identification of children with permanent childhood 
impairment has long been recognized. In the UK, the early work of the School 
Medical Service, and of the Ewings in Manchester led in the 1960s to a de facto 
national screening programme (Bamford et aI., 1998». This was configured 
around a "distraction test" screen performed by health visitors at 7-9 months, 
and a back up screen at school entry. Infant distraction test, if used properly can 
be highiy effective in identifying deafness in infancy. By the early 1980s doubts 
were being expressed about the perfonnance of the screen. These doubts led 
to notable efforts by some to improve lOT by better training, equipment and 
protocols. However, doubts remained, particularly as the limited data available 
indicated that for a large proportion of children the age of identification of 
congenital hearing impairment continued to be very late (Bamford et aI., 1998). 
Currently, the average age of detection of significant hearing loss in US is 14 
months. Even when such a test is sensitive, however, the age at which a 
hearing aid is fitted is often delayed until after the first year of life (White et aI., 
1994). The limitations of the present organizational arrangements to meet 
perceived operational requirements at a reasonable cost are also well 
recognized. 
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1.8 History of infant hearing screening 
The origins of newborn hearing screening can be traced to Sweden. In 1956, 
Wedenberg reported that the most easily observable response of an infant to 
sound is the auro-palpebral reflex. He performed hearing test on 20 infants, 
between 1 and 20 days of age, to pure tone stimulus presentations at 105 to 
115 dB SPL. In 1960, Carl-Axel Froding of Eskilstuna, Sweden evaluated the 
hearing of 2,000 newborns using a small gong and mallet, which produced a 
sound of 126-133 dB SPL. His technique was to observe the auro-palpebral 
reflex in quiet or sleeping infants. 
The initial study of newborn hearing screening in the United States came 
from a research project conducted by Marion Downs, an audiologist, and 
Graham Sterrit, a Psychologist. In 1964, Downs and Sterrit teamed to conduct a 
city-wide projed in Denver, Colorado to test all the babies born during a 1-year 
period. Using trained volunteers, and a specially designed, hand-held, battery-
operated infant hearing "screener" with a sudden onset stimulus of 90 dB SPL, 
more than 17000 newborns were evaluated. However, the researchers' review , 
of their data raised questions concerning the reliability and validity of the 
screening based on subjective behavioural observation. 
The lack of confidence in behaviourally based mass infant hearing screening 
led recommendation the use of high-risk factors to identify infants at risk for 
deafness. They argued that, if the majority of deaf babies could be identified 
through a high-risk register system, there would be no need for hearing 
screening of the entire newborn population. 
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In 1972, Joint Committee on Infant Hearing listed five high-risk alerting 
factors for congenital deafness: 
1. History of hereditary childhood hearing impairment. 
2. Rubella or other non bacterial intrauterine fetal infection (e.g., 
cytomegalovirus or herpes infection). 
3. Defect of the ear, nose or throat; malformed, low-set, or absent pinnae; 
cleft lip or palate (including submucous cleft); any residual abnormality of 
the otorhinolaryngeal system. 
4. Birth weight less than 1500 grams. 
5. Bilirubin level greater than 20mg/100ml serum. 
Also during the 1970s, considerable work was being conducted by a number of 
auditory researchers to develop objective, physiologically based hearing 
screening techniques, which could replace the widely used subjective 
behavioural observation of infant responses to acoustic stimuli. Two techniques, 
the Crib-O-Gram and Auditory Brainstem Response Audiometry had been 
found to be helpful. 
In 1982, Joint Committee on Infant Hearing expanded the risk criteria to 
seven factors. The two additional risk factors that were added to the list were 
bacterial meningitis caused by Haemophilus influenza and severe asphyxia 
demonstrated by Apgar scores has 3 or lower. The committee recommended 
that the infants should be screened, under supervision of an audiologist, prior to 
3 months of age, but no later than 6 months after birth. 
In 1990, The Joint Committee on Infant Hearing met again. The committee 
recommended that the hearing screening was to be completed prior to the at-
risk baby's discharge from the hospital, but no later than 3 months of age. 
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Further, it stated that, because of the high false- positive and false-negative 
results related to behavioural observation screening, that the initial hearing 
screening should be based on the auditory brainstem response (ABR) test. With 
concern that the ABR technique could result in some false-positive results, 
ongoing assessment and observation of the infant's auditory behaviour was 
recommended during the early intervention stages. The committee increased 
the risk criteria to ten factors. Ototoxic medications, prolonged mechanical 
ventilation and stigmata or findings associated with a syndrome known to 
include sensorineural hearing loss were added to the list. 
The National Institute on Deafness and Other Communication Disorders 
(NIDCD) sponsored a Consensus Development Conference on Early 
Identification of Hearing Impairment in Infants and Young Children early in 
1993. The NIDCD Consensus panel identified the main risk factors for hearing 
impairment as bacterial meningitis, severe head trauma, viral encephalitis or 
labyrinthitis, excessive noise exposure, exposure to ototoxic drugs, congenital 
CMV infection familial hearing impairment, infants with chronic lung disease or 
'-
diuretic therapy, and infants with repeated episodes of otitis media with 
persistent middle ear effusion. The panel concluded that the high-risk register 
approach to infant screening actually misses 50% of children who are 
eventually diagnosed with hearing impairment. Based on this fact, the expert 
panel developed a consensus statement recommending that universal hearing 
screening be implemented. It was recommended that the screening be 
conducted with a two-stage protocol consisting of evoked otoacoustic emissions 
testing (EOAE) for all infants followed by auditory brainstem response (ABR) 
screening for infants who fail the EOAE screening. The first stage of screening 
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with otoacoustic emissions was recommended to identify babies with normal 
hearing in the most cost-effective manner. The ABR second stage screening 
was recommended to confirm the accuracy of the EOAE screening and to serve 
as a mechanism for accurately referring the appropriate babies for further 
follow-up diagnostic hearing testing. 
In 1994, The Joint Committee on Infant Hearing endorsed the goal of 
universal detection of all infants with hearing loss as early as possible. The Joint 
Committee agreed that all newborns with hearing loss should be identified 
before 3 months of age, and all hearing impaired infants should be involved in 
intervention by 6 months of age. The statement does not recommend any 
specific screening technique or program protocol, per se, but recognizes that 
infant hearing program protocols will likely vary by regional location, individual 
needs, and administrative structure. 
After a meeting that has been conducted on 15-16 May 1998 in Milan, a 
European Consensus Statement on Neonatal Hearing Screening was 
produced. The statement says that neonatal hearing screening should be 
considered to be the first part of a programme of habilitation of hearing impaired 
children. The methods for identification of permanent childhood hearing 
impairment (PCHI) in the neonatal stage are effective and can be expected to 
identify at least 80% of cases of PCHI whilst incorrectly failing 2-30/0 of normally 
hearing babies in well-controlled programmes. Neonatal testing in maternity 
hospitals is more effective and less expensive than behavioural screening 
conventionally carried out at 7-9 months. Targeting neonatal testing on only 6-
8% of babies at risk of PCHI reduces cost but cannot identify more than 40-500/0 
of cases. 
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